Citations (25)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Mariana Postal, Nailú Angélica Sinicato, Simone Appenzeller & Timothy B. Niewold. (2016) Drugs in early clinical development for Systemic Lupus Erythematosus. Expert Opinion on Investigational Drugs 25:5, pages 573-583.
Read now
Read now
Tiffany Caza, Zachary Oaks & Andras Perl. (2014) Interplay of Infections, Autoimmunity, and Immunosuppression in Systemic Lupus Erythematosus. International Reviews of Immunology 33:4, pages 330-363.
Read now
Read now
Zahi Touma, Murray B Urowitz & Dafna D Gladman. (2013) Systemic lupus erythematosus: an update on current pharmacotherapy and future directions. Expert Opinion on Biological Therapy 13:5, pages 723-737.
Read now
Read now
Daniel E. Furst, Ann Clarke, Ancilla W. Fernandes, Tim Bancroft, Kavita Gajria, Warren Greth & Serban R. Iorga. (2013) Medical costs and healthcare resource use in patients with lupus nephritis and neuropsychiatric lupus in an insured population. Journal of Medical Economics 16:4, pages 500-509.
Read now
Read now
Articles from other publishers (21)
Andras Perl, Nancy Agmon-Levin, José C. Crispín & Trine N. Jorgensen. (2022) Editorial: New biomarkers for the diagnosis and treatment of systemic lupus erythematosus. Frontiers in Immunology 13.
Crossref
Crossref
Dongke Wu, Dasheng Dong, Xiongjie Bi, Yuping Liu & Yunqing Ma. (2020) Cucurbitacin IIb improved active chromatin‐induced systemic lupus erythematosus via balancing the percentage of Th17 and Treg cells. Clinical and Experimental Pharmacology and Physiology 48:3, pages 329-336.
Crossref
Crossref
Andras Perl. 2021. Systemic Lupus Erythematosus. Systemic Lupus Erythematosus
267
276
.
Hanan Al-Osaimi & Areej Althubiti. 2021. Skills in Rheumatology. Skills in Rheumatology
383
406
.
Brandon Wyman & Andras Perl. (2020) Metabolic pathways mediate pathogenesis and offer targets for treatment in rheumatic diseases. Current Opinion in Rheumatology 32:2, pages 184-191.
Crossref
Crossref
Zhi-Wei Lai, Ryan Kelly, Thomas Winans, Ivan Marchena, Ashwini Shadakshari, Julie Yu, Maha Dawood, Ricardo Garcia, Hajra Tily, Lisa Francis, Stephen V Faraone, Paul E Phillips & Andras Perl. (2018) Sirolimus in patients with clinically active systemic lupus erythematosus resistant to, or intolerant of, conventional medications: a single-arm, open-label, phase 1/2 trial. The Lancet 391:10126, pages 1186-1196.
Crossref
Crossref
Andras Perl. 2016. Systemic Lupus Erythematosus. Systemic Lupus Erythematosus
237
242
.
Patrizia Leone, Sebastiano Cicco, Angelo Vacca, Franco Dammacco & Vito Racanelli. 2016. Systemic Vasculitides: Current Status and Perspectives. Systemic Vasculitides: Current Status and Perspectives
345
359
.
Yuxin Liu, Jianghong Yu, Zachary Oaks, Ivan Marchena-Mendez, Lisa Francis, Eduardo Bonilla, Phillip Aleksiejuk, Jessica Patel, Katalin Banki, Steve K. Landas & Andras Perl. (2015) Liver injury correlates with biomarkers of autoimmunity and disease activity and represents an organ system involvement in patients with systemic lupus erythematosus. Clinical Immunology 160:2, pages 319-327.
Crossref
Crossref
Ameer Kamal & Munther Khamashta. (2014) The efficacy of novel B cell biologics as the future of SLE treatment: A review. Autoimmunity Reviews 13:11, pages 1094-1101.
Crossref
Crossref
Edward DohertyZachary OaksAndras Perl. (2014)
Increased Mitochondrial Electron Transport Chain Activity at Complex I Is Regulated by
N
-Acetylcysteine in Lymphocytes of Patients with Systemic Lupus Erythematosus
. Antioxidants & Redox Signaling 21:1, pages 56-65.
Crossref
Crossref
Andras Perl. (2013) Oxidative stress in the pathology and treatment of systemic lupus erythematosus. Nature Reviews Rheumatology 9:11, pages 674-686.
Crossref
Crossref
Giulio Fortuna & Michael T. Brennan. (2013) Systemic Lupus Erythematosus. Dental Clinics of North America 57:4, pages 631-655.
Crossref
Crossref
Ricardo J. Garcia, Lisa Francis, Maha Dawood, Zhi‐Wei Lai, Stephen V. Faraone & Andras Perl. (2013)
Brief Report: Attention Deficit and Hyperactivity Disorder Scores Are Elevated and Respond to
N
‐Acetylcysteine Treatment in Patients With Systemic Lupus Erythematosus
. Arthritis & Rheumatism 65:5, pages 1313-1318.
Crossref
Crossref
Vojislav Jovanović, Nurhuda Abdul Aziz, Yan Ting Lim, Amanda Ng Ai Poh, Sherlynn Jin Hui Chan, Eliza Ho Xin Pei, Fei Chuin Lew, Guanghou Shui, Andrew M. Jenner, Li Bowen, Eoin F. McKinney, Paul A. Lyons, Michael D. Kemeny, Kenneth G. C. Smith, Markus R. Wenk & Paul A. MacAry. (2013) Lipid Anti-Lipid Antibody Responses Correlate with Disease Activity in Systemic Lupus Erythematosus. PLoS ONE 8:2, pages e55639.
Crossref
Crossref
A Perl. (2012) Metabolic control of systemic lupus erythematosus: convergence of genetic and environmental factors on mitochondrial dysfunction and mTOR reveal treatment targets in lupus. Arthritis Research & Therapy 14:S3.
Crossref
Crossref
Tiffany N. Caza, Gergely Talaber & Andras Perl. (2012) Metabolic regulation of organelle homeostasis in lupus T cells. Clinical Immunology 144:3, pages 200-213.
Crossref
Crossref
Zhi-Wei Lai, Robert Hanczko, Eduardo Bonilla, Tiffany N. Caza, Brandon Clair, Adam Bartos, Gabriella Miklossy, John Jimah, Edward Doherty, Hajra Tily, Lisa Francis, Ricardo Garcia, Maha Dawood, Jianghong Yu, Irene Ramos, Ioana Coman, Stephen V. Faraone, Paul E. Phillips & Andras Perl. (2012)
N
-acetylcysteine reduces disease activity by blocking mammalian target of rapamycin in T cells from systemic lupus erythematosus patients: A randomized, double-blind, placebo-controlled trial
. Arthritis & Rheumatism 64:9, pages 2937-2946.
Crossref
Crossref
Ricardo Garcia & Andras Perl. 2012. Inflammatory Diseases of Blood Vessels. Inflammatory Diseases of Blood Vessels
419
432
.
. (2012) Speaker Abstracts (SP01–SP50). Rheumatology 51:suppl_1, pages i1-i14.
Crossref
Crossref
Antonia M. JoussenAntonia M. Joussen. 2012. Retinale Gefäßerkrankungen. Retinale Gefäßerkrankungen
335
398
.